VentureBeat - Latest Comments in Stealthy device maker ExploraMed raises $18.5M

Re: Stealthy device maker ExploraMed raises $18.5M

David Hamilton — Thu, 01 May 2008 03:40:50 -0000

@Raj: There's a perfectly good argument to be made against stealth, although it's entirely possible that it applies more to biotech than to devices. Mostly it's that letting the news out earlier will attract investors and boost your credibility. In the relatively short time that I've been covering startups, I've seen lots of device companies embrace the stealth strategy and essentially go dark.

Makower told me he'd like to keep his companies quiet until they're ready to sell products to the public. For another example of how well this has worked out for another multiple medical-device entrepreneur with Stanford ties, see here.

@Mike, a replacement is up to Matt Marshall. Best to direct your questions to him at matt@venturebeat.com.

Re: Stealthy device maker ExploraMed raises $18.5M

Mike — Wed, 30 Apr 2008 23:30:35 -0000

David,
Good to see you back, even if it is just for a post or two. Any word on VentureBeat finding a replacement for you?

Re: Stealthy device maker ExploraMed raises $18.5M

Raj Nihalani, MD, RAC(US) — Wed, 30 Apr 2008 03:52:23 -0000

Congratulations to ExploraMed.
I like the strategy to "run silent and run deep" and keep your competitors at bay.
I am a founder of a novel medical device technology to treat obesity. I am looking for upto 15 angel investors to put in a min of $100,000 as seed money. This will be utilized to build the prototype, secure the IP, conduct animal studies and do first in man clinical studies. I have lined up a great consultant team. I dont want to release the information on the technology until I have secured the seed money. Do I have the right strategy?

I feel this is a great opportunity for an angel investor to get a return on investment of upto 10 times.
By the time we will be ready for our exit strategy the Obesity market will be at its peak.
If any angel investors are interested in investing in this venture should contact me at 001-714-658-3039
or email me at : accessclinicaltrials@yahoo.com
Thank you.

Raj NIhalani, MD, RAC(US)
Irvine, Ca
Cell: 001-714-658-3039